| P2093 | author name string | Offner H | |
| | Vandenbark AA | |
| P2860 | cites work | T cells responsive to myelin basic protein in patients with multiple sclerosis | Q45150262 |
| | Evidence for a differential avidity model of T cell selection in the thymus | Q45155438 |
| | The expressed T cell receptor V gene repertoire of rheumatoid arthritis monozygotic twins: rapid analysis by anchored polymerase chain reaction and enzyme-linked immunosorbent assay. | Q46036058 |
| | Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen | Q46201877 |
| | Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis | Q46253564 |
| | TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system | Q46747908 |
| | Characterization of the human T cell receptor alpha-chain repertoire and demonstration of a genetic influence on V alpha usage | Q48121902 |
| | Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis | Q50127386 |
| | Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction | Q52859821 |
| | Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations. | Q52895006 |
| | Multiple sclerosis and the HLA-D region: linkage and association studies | Q58133059 |
| | An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex | Q27733448 |
| | Crystal structure of a T-cell receptor beta-chain complexed with a superantigen | Q27733857 |
| | The V-region disease hypothesis: evidence from autoimmune encephalomyelitis | Q28270565 |
| | A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 | Q28283861 |
| | Control of MHC restriction by TCR Valpha CDR1 and CDR2 | Q28589517 |
| | The specificity and orientation of a TCR to its peptide-MHC class II ligands | Q28592120 |
| | T-cell antigen receptor genes and T-cell recognition | Q29619721 |
| | Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients | Q33890993 |
| | Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes | Q33935942 |
| | Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus | Q34199681 |
| | A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis | Q36229747 |
| | T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire | Q36230696 |
| | Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility co | Q36231048 |
| | T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions | Q36231183 |
| | In a small multideterminant peptide, each determinant is recognized by a different V beta gene segment | Q36231548 |
| | Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis | Q36362874 |
| | In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens | Q36517424 |
| | Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients | Q37241657 |
| | Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis | Q37607593 |
| | Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics | Q38330987 |
| | Immunologic Mechanisms and Therapy in Multiple Sclerosis | Q40433260 |
| | T cell receptor peptides in treatment of autoimmune disease: rationale and potential | Q41027832 |
| | Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis | Q41092306 |
| | T-cell receptor variable β genes show differential expression in CD4 and CD8 T cells | Q41135810 |
| | TCR usage in human and experimental demyelinating disease | Q41166688 |
| | MHC-Restricted Depletion of Human Myelin Basic Protein-Reactive T Cells by T Cell Vaccination | Q41528229 |
| | Predictable acquisition of a new MHC recognition specificity following expression of a transfected T-cell receptor beta-chain gene | Q42074725 |
| | Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein | Q42615194 |
| | A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex | Q43405696 |
| P433 | issue | 1-2 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 9-36 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | International Reviews of Immunology | Q6052764 |
| P1476 | title | T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clones | |
| P478 | volume | 18 | |